Halozyme Therapeutics, Inc.
NasdaqGS:HALO
$ 44.71
$-0.68 (-1.50%)
$ 44.71
$-0.68 (-1.50%)
End-of-day quote: 05/17/2024

HALO - Halozyme Therapeutics Stock Prediction 2025 - 2030

20 years of reliable Halozyme Therapeutics stock forecast. The Wall Street analysts predict Outperform for HALO. See at a glance whether NasdaqGS:HALO will rise in the future.

$41.27
Forecast 2023
$69.43
Forecast 2025
$153.77
Forecast 2030
Underperform
TopGraphs Quality Ranking
Forecast 2023
$41.27
Forecast 2025
$69.43
Forecast 2030
$153.77
TopGraphs Quality Ranking
Underperform

Company Info

P/E
0.00
Beta
1.26
Price-to-book Ratio
31.94
Market Cap
5.58B
TEV
6.65 B
Dividend
$0.00
Div Yld
0.00%
Forecast 1Y
25.36%
Forecast 2Y
47.75%
Analyst Price Target
$47.50

Halozyme Therapeutics Price Chart

1M 3M YTD 1Y 2Y 5Y 10Y 20Y

Halozyme Therapeutics Stock Forecast 2023

$48.00

In the last five quarters, Halozyme Therapeutics’s Price Target has risen from $46.51 to $47.50 - a 2.13% increase. Six analysts predict that Halozyme Therapeutics’s share price will increase in the coming year, reaching $48.00. This would represent an increase of 1.05%.

7.36%
7.36
Last update: 05/18/2024

Highest Price Target $71.00

Average Price Target $48.00

Lowest Price Target $41.00

Halozyme Therapeutics Stock Prediction 2025

Halozyme Therapeutics Stock Predictions for Jan 2025.

In January 2025 analysts predict a stock price of $57.55. An increase of 28.72% compared to the previous month's estimate.

Halozyme Therapeutics Stock Predictions for Feb 2025.

In February 2025 analysts predict a stock price of $58.63. An increase of 31.14% compared to the previous month's estimate.

Halozyme Therapeutics Stock Predictions for Mar 2025.

In March 2025 analysts predict a stock price of $59.71. An increase of 33.55% compared to the previous month's estimate.

Halozyme Therapeutics Stock Predictions for Apr 2025.

In April 2025 analysts predict a stock price of $60.79. An increase of 35.97% compared to the previous month's estimate.

Halozyme Therapeutics Stock Predictions for May 2025.

In May 2025 analysts predict a stock price of $61.87. An increase of 38.39% compared to the previous month's estimate.

Halozyme Therapeutics Stock Predictions for Jun 2025.

In June 2025 analysts predict a stock price of $62.95. An increase of 40.8% compared to the previous month's estimate.

Halozyme Therapeutics Stock Predictions for Jul 2025.

In July 2025 analysts predict a stock price of $64.03. An increase of 43.22% compared to the previous month's estimate.

Halozyme Therapeutics Stock Predictions for Aug 2025.

In August 2025 analysts predict a stock price of $65.11. An increase of 45.63% compared to the previous month's estimate.

Halozyme Therapeutics Stock Predictions for Sep 2025.

In September 2025 analysts predict a stock price of $66.19. An increase of 48.05% compared to the previous month's estimate.

Halozyme Therapeutics Stock Predictions for Oct 2025.

In October 2025 analysts predict a stock price of $67.27. An increase of 50.47% compared to the previous month's estimate.

Halozyme Therapeutics Stock Predictions for Nov 2025.

In November 2025 analysts predict a stock price of $68.35. An increase of 52.88% compared to the previous month's estimate.

Halozyme Therapeutics Stock Predictions for Dec 2025.

In December 2025 analysts predict a stock price of $69.43. An increase of 55.3% compared to the previous month's estimate.

Halozyme Therapeutics Stock Forecast 2030

Stock Forecast for the Price of an Halozyme Therapeutics Share in Jan 2030.

In January 2030, analysts believe the stock price will be $150.08. An increase of 235.67% compared to the previous month's estimate.

Stock Forecast for the Price of an Halozyme Therapeutics Share in Feb 2030.

In February 2030, analysts believe the stock price will be $150.42. An increase of 236.42% compared to the previous month's estimate.

Stock Forecast for the Price of an Halozyme Therapeutics Share in Mar 2030.

In March 2030, analysts believe the stock price will be $150.75. An increase of 237.17% compared to the previous month's estimate.

Stock Forecast for the Price of an Halozyme Therapeutics Share in Apr 2030.

In April 2030, analysts believe the stock price will be $151.09. An increase of 237.92% compared to the previous month's estimate.

Stock Forecast for the Price of an Halozyme Therapeutics Share in May 2030.

In May 2030, analysts believe the stock price will be $151.42. An increase of 238.67% compared to the previous month's estimate.

Stock Forecast for the Price of an Halozyme Therapeutics Share in Jun 2030.

In June 2030, analysts believe the stock price will be $151.76. An increase of 239.42% compared to the previous month's estimate.

Stock Forecast for the Price of an Halozyme Therapeutics Share in Jul 2030.

In July 2030, analysts believe the stock price will be $152.09. An increase of 240.17% compared to the previous month's estimate.

Stock Forecast for the Price of an Halozyme Therapeutics Share in Aug 2030.

In August 2030, analysts believe the stock price will be $152.43. An increase of 240.92% compared to the previous month's estimate.

Stock Forecast for the Price of an Halozyme Therapeutics Share in Sep 2030.

In September 2030, analysts believe the stock price will be $152.76. An increase of 241.67% compared to the previous month's estimate.

Stock Forecast for the Price of an Halozyme Therapeutics Share in Oct 2030.

In October 2030, analysts believe the stock price will be $153.10. An increase of 242.42% compared to the previous month's estimate.

Stock Forecast for the Price of an Halozyme Therapeutics Share in Nov 2030.

In November 2030, analysts believe the stock price will be $153.43. An increase of 243.17% compared to the previous month's estimate.

Stock Forecast for the Price of an Halozyme Therapeutics Share in Dec 2030.

In December 2030, analysts believe the stock price will be $153.77. An increase of 243.92% compared to the previous month's estimate.

P/E
0.00
Beta
1.26
Price-to-book Ratio
31.94
Market Cap
5.58B
TEV
6.65 B
Dividend
$0.00
Div Yld
0.00%
Forecast 1Y
25.36%
Forecast 2Y
47.75%
Analyst Price Target
$47.50

Halozyme Therapeutics Analyst Ratings Frequently Asked Questions

Who are the analysts watching Halozyme Therapeutics, Inc.?

The following analysts have recently covered Halozyme Therapeutics:

Benchmark Company
Goldman Sachs
J.P. Morgan
JMP Securities
Marktfeld
Piper Sandler Companies
Evercore ISI
Morgan Stanley
H.C. Wainwright & Co.
Leerink Partners LLC
Wells Fargo Securities, LLC
TD Cowen
Baptista Research
(This information refers to the last 90 days.)

Who are the sell-side analysts watching Halozyme Therapeutics, Inc.?

The following sell-side analysts have recently covered Halozyme Therapeutics:

Wasserman, Robert Mark
Jenkins, Corinne
Fye, Jessica Macomber
Butler, Jason Nicholas
Paraskevopoulos, Michail
Catanzaro, Joseph Michael
DiFiore, Michael Gennaro
Risinger, David Reed
Kapoor, Mitchell Swaroop
Purohit, Vikram
Bansal, Mohit
Smith, Brendan Mychal
Majumdar, Ishan
(This information refers to the last 90 days.)